FDA Investigator Charvais S Bogan
Charvais S Bogan has conducted inspections on 23 sites in 1 countries as of 05 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
05 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Charvais S Bogan:
Alexis O Robinson,
Alissa C Rice,
Anetra E Wyatt,
Anthony D Peterson,
Barbara D Wright,
Brittany N Ross,
Caitlin L Almonrode,
Casey L Hamblin,
Charvais S Hill,
Cherie T Parker,
Cheryl L Watson,
Christopher J Adams,
Cody D Rickman,
Denise J Taylor,
Donna D Gallien, MPH,
Emily E Smith,
Erica M Katherine,
Francis A Guidry,
Gloria J Horner,
Grant D Jones,
Jacquelyn Bradford,
Jason K Ferry,
Javelle P Spann,
Juanelma H Palmer,
Karen Gale Sego,
Kate E Jesse,
Katherine A Bearss,
Konsuela Y Glass,
Krista W Whitten,
Lawrence A Butler,
Margaret E Slimbach,
Mary A Millner,
Melanie L Drayton,
Samantha J Bradley,
Shayla G Turnipseed,
Shirhonda D Thorn,
Tamira D Wesley,
Thomas B Smith,
Thomas O Morgan,
Tony E Bable,
Whitney M White
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more